524414 NORRIS

Norris Medicines Share Price

₹20.46 -1.07 (-4.97%)

24 Nov, 2024 02:31

SIP TrendupStart SIP in NORRIS

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 13.67%
  • Over 3 Month + 48.05%
  • Over 6 Month + 70.5%
  • Over 1 Year + 65.94%
SIP Lightning

Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!

Invest Now

Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Norris Medicines Financials

Norris Medicines Technicals

EMA & SMA

Current Price
₹20.46
-1.07 (-4.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 8
  • stock-up_img
  • Bearish Moving Average 8
  • 20 Day
  • ₹21.36
  • 50 Day
  • ₹19.37
  • 100 Day
  • ₹17.61
  • 200 Day
  • ₹16.16

Resistance and Support

20.67 Pivot Speed
  • R3 21.53
  • R2 21.31
  • R1 20.89
  • S1 20.25
  • S2 20.03
  • S3 19.61

What's your outlook on Norris Medicines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines has an operating revenue of Rs. 4.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -19% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Norris Medicines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-14 Quarterly Results
2023-12-29 Others Inter alia : 1. To Consider and approve Authorized Signatory for Bank Operations. 2. To Consider and recommend Mr. Vimal Shah as a Director of the Company subject to Members approval.

Norris Medicines F&O

Norris Medicines Shareholding Pattern

34.01%
0.01%
0.06%
20.71%
45.21%

About Norris Medicines

  • NSE Symbol
  • NORRIS
  • BSE Symbol
  • 524414
  • Managing Director
  • Mr. Vimal Shah
  • ISIN
  • INE744C01029

Similar Stocks to Norris Medicines

Norris Medicines FAQs

Norris Medicines share price is ₹20 As on 24 November, 2024 | 02:17

The Market Cap of Norris Medicines is ₹20.5 Cr As on 24 November, 2024 | 02:17

The P/E ratio of Norris Medicines is -24.9 As on 24 November, 2024 | 02:17

The PB ratio of Norris Medicines is -1.5 As on 24 November, 2024 | 02:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23